Quarterly results · DIVISLAB
DIVI S LABORATORIES LTD reported revenue of ₹3,676 cr and net profit of ₹1,127 cr in Q2 FY27 (quarter ended 30 Sept 2026). Below is the full quarter-wise results table with revenue, operating profit, margins, tax, EPS and annual history — updated when Yahoo Finance publishes updated financial statements; exchange filings can appear earlier.
Next results date
7 Nov 2026
To consider and approve the financial results for the period ended September 30, 2026
| Quarter | Q2 FY27 |
|---|---|
| Quarter ended | 30 Sept 2026 |
| Revenue | ₹3,676 cr |
| Revenue YoY | — |
| Operating profit | ₹1,424 cr |
| Operating margin | 38.7% |
| Net profit | ₹1,127 cr |
| Net profit YoY | — |
| Net profit QoQ | +24.9% |
| Net margin | 30.7% |
| Basic EPS | ₹42.49 |
| TTM revenue | ₹12,191 cr |
| TTM net profit | ₹3,363 cr |
| TTM net margin | 27.6% |
DIVI S LABORATORIES LTD (DIVISLAB) has reported its Q2 FY27 results for the quarter ended 2026-09-30. The company posted revenue of ₹3,676 cr and a net profit of ₹1,127 cr, translating into earnings per share of ₹42.49.
Operating profit for the quarter stood at ₹1,424 cr, an operating margin of 38.7%.
Revenue
₹3,676 cr
— YoY
Net profit
₹1,127 cr
— YoY
Operating profit
₹1,424 cr
— YoY
EPS
₹42.49
— YoY
Swipe sideways to see all columns →
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q2 FY272026-09-30 | ₹3,676 cr | ₹1,424 cr | ₹1,127 cr | 38.7% | 30.7% | ₹42.49 | — | +24.9% |
| Q1 FY272026-06-30 | ₹3,080 cr | ₹1,122 cr | ₹902 cr | 36.4% | 29.3% | ₹33.95 | +65.5% | +20.1% |
| Q4 FY262026-03-31 | ₹2,831 cr | ₹814 cr | ₹751 cr | 28.8% | 26.5% | ₹28.31 | +13.4% | +28.8% |
| Q3 FY262025-12-31 | ₹2,604 cr | ₹772 cr | ₹583 cr | 29.6% | 22.4% | ₹21.98 | — | +7.0% |
| Q1 FY262025-06-30 | ₹2,410 cr | ₹617 cr | ₹545 cr | 25.6% | 22.6% | ₹20.49 | — | -17.7% |
| Q4 FY252025-03-31 | ₹2,585 cr | ₹779 cr | ₹662 cr | 30.1% | 25.6% | ₹24.93 | — | — |
| TTM (last 4 quarters) | ₹12,191 cr | ₹4,132 cr | ₹3,363 cr | 33.9% | 27.6% | ₹126.73 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
| Particulars | Q2 FY272026-09-30 | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q1 FY262025-06-30 | Q4 FY252025-03-31 |
|---|---|---|---|---|---|---|
| Revenue / Sales | ₹3,676 cr | ₹3,080 cr | ₹2,831 cr | ₹2,604 cr | ₹2,410 cr | ₹2,585 cr |
| Total expenses | ₹2,265 cr | ₹1,958 cr | ₹2,017 cr | ₹1,832 cr | ₹1,793 cr | ₹1,806 cr |
| Gross profit | — | ₹2,094 cr | ₹1,712 cr | ₹1,659 cr | ₹1,454 cr | ₹1,604 cr |
| Operating profit (EBIT) | ₹1,424 cr | ₹1,122 cr | ₹814 cr | ₹772 cr | ₹617 cr | ₹779 cr |
| Operating margin | 38.7% | 36.4% | 28.8% | 29.6% | 25.6% | 30.1% |
| Interest cost | ₹13 cr | ₹6 cr | ₹6 cr | ₹6 cr | ₹3 cr | ₹1 cr |
| Profit before tax | ₹1,505 cr | ₹1,180 cr | ₹963 cr | ₹780 cr | ₹733 cr | ₹864 cr |
| Tax expense | ₹378 cr | ₹278 cr | ₹212 cr | ₹197 cr | ₹188 cr | ₹202 cr |
| Effective tax rate | 25.1% | 23.6% | 22.0% | 25.3% | 25.6% | 23.4% |
| Net profit (PAT) | ₹1,127 cr | ₹902 cr | ₹751 cr | ₹583 cr | ₹545 cr | ₹662 cr |
| Net profit margin | 30.7% | 29.3% | 26.5% | 22.4% | 22.6% | 25.6% |
| Basic EPS | ₹42.49 | ₹33.95 | ₹28.31 | ₹21.98 | ₹20.49 | ₹24.93 |
| Diluted EPS | — | ₹33.95 | ₹28.31 | ₹21.98 | ₹20.49 | ₹24.93 |
| Growth | Q2 FY27 | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q1 FY26 | Q4 FY25 |
|---|---|---|---|---|---|---|
| Revenue YoY | — | +27.8% | +9.5% | — | — | — |
| Revenue QoQ | +19.4% | +8.8% | +8.7% | +8.0% | -6.8% | — |
| Operating profit YoY | — | +81.8% | +4.5% | — | — | — |
| Operating profit QoQ | +26.9% | +37.8% | +5.4% | +25.1% | -20.8% | — |
| Net profit YoY | — | +65.5% | +13.4% | — | — | — |
| Net profit QoQ | +24.9% | +20.1% | +28.8% | +7.0% | -17.7% | — |
| EPS YoY | — | +65.7% | +13.6% | — | — | — |
| EPS QoQ | +25.2% | +19.9% | +28.8% | +7.3% | -17.8% | — |
Full-year performance for DIVI S LABORATORIES LTD, useful for reading each quarter in context.
| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|---|---|---|---|
| Revenue / Sales | ₹10,476 cr | ₹9,325 cr | ₹7,796 cr | ₹7,665 cr |
| Total expenses | ₹7,497 cr | ₹6,754 cr | ₹5,964 cr | ₹5,638 cr |
| Gross profit | ₹6,195 cr | ₹5,455 cr | ₹4,527 cr | ₹4,487 cr |
| Operating profit (EBIT) | ₹2,979 cr | ₹2,571 cr | ₹1,832 cr | ₹2,027 cr |
| Operating margin | 28.4% | 27.6% | 23.5% | 26.4% |
| Interest cost | ₹23 cr | ₹2 cr | ₹3 cr | ₹0 cr |
| Profit before tax | ₹3,388 cr | ₹2,916 cr | ₹2,163 cr | ₹2,369 cr |
| Tax expense | ₹820 cr | ₹725 cr | ₹563 cr | ₹545 cr |
| Effective tax rate | 24.2% | 24.9% | 26.0% | 23.0% |
| Net profit (PAT) | ₹2,568 cr | ₹2,191 cr | ₹1,600 cr | ₹1,824 cr |
| Net profit margin | 24.5% | 23.5% | 20.5% | 23.8% |
| Basic EPS | ₹96.75 | ₹82.53 | ₹60.27 | ₹68.69 |
| Diluted EPS | ₹96.75 | ₹82.53 | ₹60.27 | ₹68.69 |
Topline for Q2 FY27 came in at ₹3,676 cr, and ₹3,080 cr in the preceding Q1 FY27 quarter.
On a sequential basis revenue grew +19.4%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹2,265 cr, or 61.6% of revenue.
Net profit of ₹1,127 cr works out to a net margin of 30.7%.
Below the operating line, DIVI S LABORATORIES LTD reported profit before tax of ₹1,505 cr, a tax charge of ₹378 cr (effective rate 25.1%), interest cost of ₹13 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹902 cr in Q1 FY27 to ₹1,127 cr in Q2 FY27, a change of +24.9%.
Across the trailing four quarters DIVI S LABORATORIES LTD has generated revenue of ₹12,191 cr and net profit of ₹3,363 cr, a trailing net margin of 27.6%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹10,476 cr with net profit of ₹2,568 cr and EPS of ₹96.75, versus the prior year where revenue grew +12.3% and profit grew +17.2%.
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.
DIVI S LABORATORIES LTD has intimated the exchange that its board meets on 7 Nov 2026 to approve financial results. The figures shown here update when Yahoo Finance publishes the corresponding statement data, which can lag the filing.
Financial figures here are supplied through Yahoo Finance fundamentals and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
In Q2 FY27 (quarter ended 30 Sept 2026), DIVI S LABORATORIES LTD reported revenue of ₹3,676 cr and net profit of ₹1,127 cr. EPS stood at ₹42.49.
DIVI S LABORATORIES LTD posted a net profit margin of 30.7% and an operating margin of 38.7% in Q2 FY27. On a trailing twelve-month basis, revenue is ₹12,191 cr and net profit ₹3,363 cr.
DIVI S LABORATORIES LTD net profit changed +24.9% quarter on quarter, from ₹902 cr in Q1 FY27 to ₹1,127 cr in Q2 FY27.
The board of DIVI S LABORATORIES LTD meets on 7 Nov 2026 to consider and approve the financial results, as per the exchange filing.
Our latest DIVISLAB results coverage — "Divi's Laboratories Limited Q2 FY27 Results: Net Profit ₹1,127 cr" — breaks down revenue, profit, margins and management commentary.
For FY26, DIVI S LABORATORIES LTD reported full-year revenue of ₹10,476 cr and net profit of ₹2,568 cr, with EPS of ₹96.75.
Past results dates for DIVISLAB will be listed here from the exchange calendar.
Results dates: NSE board-meeting calendar. Financial figures: Yahoo Finance fundamentals, not a direct exchange filing feed. Last successful data fetch 7 Nov 2026. Figures can be delayed; results change only when the provider publishes them. For information only, not investment advice.
